Shanghai Henlius Biotech, Inc. (Stock code: 2696) announced in an official document dated 3 March 2026 that a board meeting will be held on Friday, 20 March 2026. The agenda includes reviewing and approving the final results of the company and its subsidiaries for the year ended 31 December 2025, considering a possible final dividend, and addressing other business matters.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments